From: Use of large scale EHR data to evaluate A1c utilization among sickle cell disease patients
Facility characteristics | HF cohort n = 393 facilities | Adherent (ratio = 0) N = 74 facilities | NA-1 (0 < ratio < 0.126) N = 61 facilities | NA-4 (ratio > 0.363) N = 60 facilities |
---|---|---|---|---|
SCD patients: Mean (Range)* | 110 (1–2803) | 34 (1–1661) | 254 (8–2003) | 13 (1–147) |
Prevalence of SCD patients with A1c test: Mean % (Range)** | 11 (0–100) | 0 (0–0) | 7 (0.2–12.5) | 67 (36.5–100) |
Census region: No. of facilities (%) | Â | Â | Â | Â |
 Midwest** | 79 (20) | 19 (26) | 7 (11) | 13 (21) |
 Northeast* | 68 (17) | 9 (12) | 7 (11) | 17 (28) |
 South** | 162 (41) | 23 (31) | 39 (64) | 9 (15) |
 West* | 84 (21) | 23 (31) | 8 (13) | 21 (35) |
Bed size range: No. of facilities (%) | Â | Â | Â | Â |
 < 5* | 134 (34) | 20 (27) | 14 (23) | 27 (44) |
 5–99** | 105 (27) | 39 (53) | 12 (20) | 18 (30) |
 100–199* | 59 (15) | 7 (10) | 12(20) | 6 (10) |
 200–299** | 45 (12) | 3 (4) | 15 (26) | 6 (10) |
 300–499** | 29 (7) | 1 (1) | 6 (10) | 1 (2) |
 500+ | 21 (5) | 4 (5) | 1 (1) | 2 (3) |
Teaching: No. of facilities (%)** | 109 (28) | 14 (19) | 28 (46) | 13 (21) |
Urban: No. of facilities (%) | 300 (76) | 55 (74) | 48 (79) | 48 (79) |
Acute care: No. of facilities (%) | 286 (73) | 59 (80) | 51 (84) | 41 (67) |